Abstract 261: Foxo4 Promotes Early Inflammatory Response Upon Myocardial Infarction via Endothelial Arg1

RATIONALE Inflammation in post-myocardial infarction (MI) is necessary for myocyte repair and wound healing. Unfortunately, it is also a key component of subsequent heart failure pathology. Transcription factor forkhead box O4 (FoxO4) regulates a variety of biological processes, including inflammation. However, its role in MI remains unknown. OBJECTIVE To test the hypothesis that FoxO4 promotes early post-MI inflammation via endothelial arginase 1 (Arg1). METHODS AND RESULTS We induced MI in wild-type and FoxO4(-/-) mice. FoxO4(-/-) mice had a significantly higher post-MI survival, better cardiac function, and reduced infarct size. FoxO4(-/-) hearts had significantly fewer neutrophils, reduced expression of cytokines, and competitive nitric oxide synthase inhibitor Arg1. We generated conditional FoxO4 knockout mice with FoxO4 deleted in cardiac mycoytes or endothelial cells. FoxO4 endothelial cell-specific knockout mice showed significant post-MI improvement of cardiac function and reduction of neutrophil accumulation and cytokine expression, whereas FoxO4 cardiac mycoyte-specific knockout mice had no significant difference in cardiac function and post-MI inflammation from those of control littermates. FoxO4 binds the Foxo-binding site in the Arg1 promoter and activates Arg1 transcription. FoxO4 knockdown in human aortic endothelial cells upregulated nitric oxide on ischemia and suppressed monocyte adhesion that can be reversed by ectopic-expression of Arg1. Furthermore, chemical inhibition of Arg1 in wild-type mice had similar cardioprotection and reduced inflammation after MI as FoxO4 inactivation and administration of nitric oxide synthase inhibitor to FoxO4 KO mice reversed the beneficial effects of FoxO4 deletion on post-MI cardiac function. CONCLUSIONS FoxO4 activates Arg1 transcription in endothelial cells in response to MI, leading to downregulation of nitric oxide and upregulation of neutrophil infiltration to the infarct area.

[1]  N. Frangogiannis.  Inflammation in cardiac injury, repair and regeneration , 2015, Current opinion in cardiology.

[2]  A. Shatanawi,et al.  Angiotensin II-Induced Arterial Thickening, Fibrosis and Stiffening Involves Elevated Arginase Function , 2015, PloS one.

[3]  R. Schulz,et al.  Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart , 2015, Front. Physiol..

[4]  Christoph D. Rau,et al.  Mapping Genetic Contributions to Cardiac Pathology Induced by Beta-Adrenergic Stimulation in Mice , 2015, Circulation. Cardiovascular genetics.

[5]  C. Mineo,et al.  Genetic variants of ApoE and ApoER2 differentially modulate endothelial function , 2014, Proceedings of the National Academy of Sciences.

[6]  J. Pernow,et al.  Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus , 2014, PloS one.

[7]  D. Brenner,et al.  Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.

[8]  N. Sethy,et al.  Hypobaric hypoxia induced arginase expression limits nitric oxide availability and signaling in rodent heart. , 2014, Biochimica et biophysica acta.

[9]  J. Pernow,et al.  Arginase as a target for treatment of myocardial ischemia-reperfusion injury. , 2013, European journal of pharmacology.

[10]  S. Morris,et al.  Shaping the Murine Macrophage Phenotype: IL-4 and Cyclic AMP Synergistically Activate the Arginase I Promoter , 2013, The Journal of Immunology.

[11]  N. Frangogiannis,et al.  Targeting inflammatory pathways in myocardial infarction , 2013, European journal of clinical investigation.

[12]  J. Lundberg,et al.  Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity , 2013, Proceedings of the National Academy of Sciences.

[13]  C. Jung,et al.  Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? , 2013, Cardiovascular research.

[14]  C. Jung,et al.  Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia–reperfusion in a rat model , 2013, Acta physiologica.

[15]  P. Doevendans,et al.  Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. , 2013, Biochimica et biophysica acta.

[16]  J. Liao.  Linking endothelial dysfunction with endothelial cell activation. , 2013, Journal of Clinical Investigation.

[17]  A. Eijkelenboom,et al.  FOXOs: signalling integrators for homeostasis maintenance , 2013, Nature reviews. Molecular cell biology.

[18]  C. Jung,et al.  Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus , 2012, Circulation.

[19]  M. Iruela-Arispe,et al.  Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling. , 2012, Developmental cell.

[20]  S. Morris.  Arginases and arginine deficiency syndromes , 2012, Current opinion in clinical nutrition and metabolic care.

[21]  Qing-Jun Zhang,et al.  FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells. , 2011, Atherosclerosis.

[22]  F. Gurdol,et al.  Serum levels of arginase I are associated with left ventricular function after myocardial infarction. , 2011, Clinical biochemistry.

[23]  R. DePinho,et al.  FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative Stress* , 2010, The Journal of Biological Chemistry.

[24]  G. Faggian,et al.  Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation , 2010, Thrombosis and Haemostasis.

[25]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[26]  M. Feki,et al.  Association of rs2781666 G/T polymorphism of arginase I gene with myocardial infarction in Tunisian male population. , 2010, Clinical biochemistry.

[27]  Christian Jung,et al.  Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. , 2010, Cardiovascular research.

[28]  R. Kloner,et al.  Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities , 2010, Heart Failure Reviews.

[29]  S. Neubauer,et al.  Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart , 2009, American journal of physiology. Heart and circulatory physiology.

[30]  R. DePinho,et al.  FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. , 2009, Gastroenterology.

[31]  S. Morris,et al.  Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.

[32]  M. Daemen,et al.  Mouse strain determines the outcome of wound healing after myocardial infarction. , 2009, Cardiovascular research.

[33]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[34]  M. Gladwin,et al.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. , 2008, Current molecular medicine.

[35]  K. Chatila,et al.  Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. , 2008, The American journal of pathology.

[36]  A. Meixner,et al.  S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction , 2007, Nature Cell Biology.

[37]  Randall J. Lee,et al.  Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. , 2007, Journal of applied physiology.

[38]  R. DePinho,et al.  FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription , 2007, Molecular and Cellular Biology.

[39]  P J de Feyter,et al.  Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. , 2006, European heart journal.

[40]  Wei He,et al.  A FoxO–Smad synexpression group in human keratinocytes , 2006, Proceedings of the National Academy of Sciences.

[41]  E. Olson,et al.  Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. , 2005, Developmental cell.

[42]  S. Morris,et al.  Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. , 2005, Gene.

[43]  B. Rollins,et al.  CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.

[44]  Chaoxia He,et al.  Hypoxia/reoxygenation stimulates Ca2+-dependent ICAM-1 mRNA expression in human aortic endothelial cells. , 2004, Biochemical and biophysical research communications.

[45]  J. Epstein,et al.  Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia , 2004, Pediatric Research.

[46]  A. Dinopoulos,et al.  Neutrophil depletion reduces myocardial reperfusion morbidity. , 2004, The Annals of thoracic surgery.

[47]  Mario Huerta,et al.  Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN , 2003, Nucleic Acids Res..

[48]  R. Hammer,et al.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.

[49]  S. Morris,et al.  Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. , 1998, American journal of physiology. Endocrinology and metabolism.

[50]  L. Becker,et al.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. , 1989, Circulation.

[51]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[52]  R Roberts,et al.  Deleterious effects of methylprednisolone in patients with myocardial infarction. , 1976, Circulation.

[53]  S. Goldstein.  Letter: Pacing the WPW patient. , 1976, Circulation.